(20 days)
Not Found
No
The device description focuses on mechanical components and actions (rotation, dilation) and the performance studies are standard mechanical, material, and biological tests. There is no mention of data processing, algorithms, or learning.
No.
The device facilitates the removal of cardiac leads, indwelling catheters, and foreign objects by dilating tissue, which is a preparatory step for removal, not a therapeutic action itself.
No
This device is described as an "intra-operative device" intended for the "percutaneous dilation of tissue to facilitate removal of cardiac leads, indwelling catheters, and foreign objects." This function is interventional/therapeutic, not diagnostic.
No
The device description clearly outlines physical components (proximal handle drive mechanism, distal dilation sheath, outer support sheath) and mechanical actions (advanced, withdrawn, rotated, actuating trigger, rotary dilation mechanism, axial actuation, cam path). There is no mention of software as a component or function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "percutaneous dilation of tissue to facilitate removal of cardiac leads, indwelling catheters, and foreign objects." This is a surgical/interventional procedure performed directly on a patient's body.
- Device Description: The description details a mechanical device with a handle, sheath, and rotating dilation mechanism used to physically manipulate tissue. This is consistent with a surgical tool.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples) to provide information for diagnosis, monitoring, or treatment.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is used in vivo (inside the body) for a procedural purpose.
N/A
Intended Use / Indications for Use
The TightRail and TightRail Mini Rotating Dilator Sheaths are intended for use in patients requiring the percutaneous dilation of tissue to facilitate removal of cardiac leads, indwelling catheters and foreign objects
Product codes (comma separated list FDA assigned to the subject device)
DRE
Device Description
The TightRail and TightRail Mini Rotating Dilator Sheaths are intra-operative devices. The devices consist of a proximal handle drive mechanism with a distal dilation sheath. Each rotating dilator sheath is packaged with an optional outer support sheath. The dilator sheath is advanced, withdrawn, and rotated about the lead, catheter, or foreign object to be removed. Actuating the trigger on the proximal handle activates a rotary dilation mechanism sheathed at the distal terminus of the dilation sheath. Rotation of the inner shaft is translated to axial actuation of the dilation mechanism via a cam path contained within the distal components. Actuation of the distal dilation mechanism causes dilation of tissue and fibrous attachments surrounding the object targeted for removal thereby facilitating removal of said object. For the TightRail the diameter sizes range from 9 French (F) to 13 F with a nominal effective length of 47.5cm. For the TightRail Mini, the diameter sizes range from 9 French (F) to 11 F with a nominal effective length of 15.5 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following testing was conducted to validate and verify that the subject device met all requirements of as identified in the risk analysis that was performed.
Design Verification and Validation Testing
- Dimensional Verification
- Tri Coil Tensile Test
- Tri Coil Torsional Test
- Axial Load Test
- Outer Sheath Axial Load Test
- Radio-Detectability Test
- Corrosion Resistance Test
- Simulated Use Testing*
- Dimensional Verification at 2 years
- Outer Sheath Axial Load Test at 2 years
- Simulated Use Test at 2 years
- Package Integrity at 2 years
- Simulated Distribution (Shipping and Simulated Environmental Conditioning) Test
Sterilization:
- Product adoption equivalency per AAMI TIR:28-2009
Biocompatibility:
- Cytotoxicity
- Sensitization
- Intracutaneous Reactivity
- Acute Systemic Toxicity
- C3a Complement Activation
- SC5b-9 Complement Activation
- Direct Hemolysis
- Indirect Hemolysis
- In Vivo Thrombogenicity-Ovine Model
- Genotoxicity - Ames Test
- Material Mediated Pyrogenicity
Preclinical and Clinical Data:
Preclinical and clinical data was not required to demonstrate substantial equivalence. The design characteristics of the subject device are similar to the design verification and validation test results demonstrated that the subject device is as safe and clinically effective as the predicate device.
Key results: The design characteristics of the subject device are similar to the design verification and validation test results demonstrated that the subject device is as safe and clinically effective as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1310 Vessel dilator for percutaneous catheterization.
(a)
Identification. A vessel dilator for percutaneous catheterization is a device which is placed over the guide wire to enlarge the opening in the vessel, and which is then removed before sliding the catheter over the guide wire.(b)
Classification. Class II (performance standards).
0
Public Health Service
Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines connecting them. The profiles are stacked on top of each other, creating a sense of unity and connection.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 4, 2015
Spectranetics, Inc. Christopher McLellan Senior Regulatory Specialist 9965 Federal Drive Colorado Springs, Colorado 80921
Re: K150360
Trade/Device Name: TightRail Rotating Dilator Sheath, TightRail Mini Rotating Dilator Sheath Regulation Number: 21 CFR 870.1310 Regulation Name: Vessel Dilator For Percutaneous Catheterization Regulatory Class: Class II Product Code: DRE Dated: February 11, 2015 Received: February 13, 2015
Dear Christopher McLellan,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply
1
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
M.A. Hillebrand
for
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K150360
Device Name
TightRail and TightRail Mini Rotating Dilator Sheaths
Indications for Use (Describe)
The TightRail and TightRail Mini Rotating Dilator Sheaths are in patients requiring the percutaneous dilation of tissue to facilitate removal of cardiac leads, indwelling catheters, and foreign objects
Type of Use (Select one or both, as applicable)
ال Prescription Use (Part 21 CFR 801 Subpart D)
_ Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
Image /page/3/Picture/1 description: The image shows the Spectranetics logo. The logo features a blue diamond shape with a white circle inside, followed by the word "Spectranetics" in blue, bold font. Below the word "Spectranetics" is the tagline "Always Reaching Farther" in a smaller, lighter blue font.
510(k) Summary
This 510(k) summary was prepared in accordance with 21 CFR 807.92
Prepared on 11 February 2015
| 510(k) Submitter / Holder: | Spectranetics
9965 Federal Drive
Colorado Springs, CO 80921-3617
Establishment Registration No: 3007284006 | |
|----------------------------|---------------------------------------------------------------------------------------------------------------------------------------|--|
| Contact: | Christopher S. McLellan
Sr. Regulatory Specialist
Office: 719-447-2475Fax: 719.447.2040
Email: christopher.mclellan@spnc.com | |
| Subject Device | | |
| Device Trade Name: | TightRail and TightRail Mini Rotating Dilator Sheaths | |
| Device Common Name: | Sheath | |
| Device Class: | II | |
| Classification Regulation: | 21 CFR 870.1310 | |
| Regulation Description: | Vessel dilator for percutaneous catheterization | |
| Product Code: | DRE | |
| 510(k) Type: | Special | |
| Model Numbers: | 545-009, 545-011, 545-013, 540-009, 540-011 | |
Predicate Device
The TightRail Mini was compared to the following legally marketed predicate device:
| 510(k) Number: | K142546 |
|---|---|
| Manufacturer: | Spectranetics |
| Trade Name: | TightRail and TightRail Mini |
| Device Common Name: | Sheath |
| Model Numbers: | 545-009, 545-011, 545-013, 540-009, 540-011 |
Device Description
The TightRail and TightRail Mini Rotating Dilator Sheaths are intra-operative devices. The devices consist of a proximal handle drive mechanism with a distal dilation sheath. Each rotating dilator sheath is packaged with an optional outer support sheath. The dilator sheath is advanced, withdrawn, and rotated about the lead, catheter, or foreign object to be removed. Actuating the trigger on the proximal handle activates a rotary dilation mechanism sheathed at the distal terminus of the dilation sheath. Rotation of the inner shaft is translated to axial actuation of the dilation mechanism via a cam path contained within the distal components. Actuation of the distal dilation mechanism causes dilation of tissue and fibrous attachments surrounding the object targeted for removal thereby facilitating removal of said object. For the TightRail the diameter sizes range from 9 French (F) to 13 F with a nominal effective length of 47.5cm. For the TightRail Mini, the diameter sizes range from 9 French (F) to 11 F with a nominal effective length of 15.5 cm.
Intended and Indications for Use
The TightRail and TightRail Mini Rotating Dilator Sheaths are intended for use in patients requiring the percutaneous dilation of tissue to facilitate removal of cardiac leads, indwelling catheters and foreign objects
The Spectranetics Corporation 9965 Federal Drive, Colorado Springs, CO 80921 Tel: 719-447-2000 · Fax: 719-447-2022
4
Technological Characteristics
The TightRail and TightRail Mini Rotating Dilator Sheaths feature the same performance characteristics as the predicate device (K142546 – TightRail and Tight Rail Mini Rotating Dilator Sheath). There are no significant changes to the function of the device. Changes have been made to material of the trigger pin. The subject and predicate are otherwise identical with regards to technological characteristics.
Performance Data1
The following testing was conducted to validate and verify that the subject device met all requirements of as identified in the risk analysis that was performed.
Design Verification and Validation Testing
- Dimensional Verification ●
- Tri Coil Tensile Test ●
- Tri Coil Torsional Test .
- Axial Load Test ●
- Outer Sheath Axial Load Test
- Radio-Detectability Test .
- Corrosion Resistance Test
- Simulated Use Testing*
- Dimensional Verification at 2 years ●
- Outer Sheath Axial Load Test at 2 years
- Simulated Use Test at 2 years ●
- Package Integrity at 2 years o
- Simulated Distribution (Shipping and Simulated Environmental Conditioning) Test ●
Sterilization:
- Product adoption equivalency per AAMI TIR:28-2009 o
Biocompatibility:
- Cytotoxicity
- Sensitization ●
- Intracutaneous Reactivity o
- Acute Systemic Toxicity ●
- C3a Complement Activation
- SC5b-9 Complement Activation
- Direct Hemolysis ●
- Indirect Hemolysis ●
- In Vivo Thrombogenicity-Ovine Model
- Genotoxicity - Ames Test
- Material Mediated Pyrogenicity ●
Preclinical and Clinical Data:
Preclinical and clinical data was not required to demonstrate substantial equivalence. The design characteristics of the subject device are similar to the design verification and validation test results demonstrated that the subject device is as safe and clinically effective as the predicate device.
Substantial Equivalence:
Based on the similarities in design between the subject and the performance testing performed, the TightRail and TightRail Mini Rotating Dilator Sheaths, with the new trigger pin material, are substantially equivalent to the previously cleared TightRail Mini Rotating Dilator Sheaths (K142546).
1 All testing marked with an * is summarized in this submission. All other testing is leveraged from K142546.